Hungarian Investment Promotion Agency

The Servier Group is the second largest pharmaceutical group in France. They have 16 manufacturing bases, 15 international therapy research centres and 5 research and development (R&D) centres worldwide, and their products are available in 150 countries.

Egis' product portfolio consists of more than 600 products in total. Their main therapeutic areas are the cardiovascular and central nervous system, while they also offer advanced therapeutic options with oncology and gynaecological preparations. Besides Hungary, Egis sells its products under Egis' brand names in 17 countries through its network of subsidiaries and representative offices, while its product range is available in 60 countries, in total.

As an element of the investment package, Egis has completed its oncology product development and manufacturing infrastructure. The company has installed state-of-the-art technological innovations in the newly established finished product manufacturing plant for the production of pharmaceutical products requiring special manufacturing conditions.

A brand-new packaging plant has also been set up as another element of the investment. The site in Körmend performs more than half of the company's packaging tasks; the old packaging plant has been operating with full utilization and there was no possibility to expand it. The new packaging plant purchased at the beginning of 2018 on the property next to the factory unit, can be further expanded in the future, so it can meet the growing market requirements in a flexible way.